Company news
Pacira BioSciences, Inc. news in 2021
Pacira BioSciences, Inc.'s news releases, calls and decks from 2021, newest first.
Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B
December 8, 2021
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021
December 6, 2021
Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 22, 2021
Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management
November 18, 2021
Pacira BioSciences to Present at the Jefferies London Healthcare Conference
November 9, 2021
Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021
November 8, 2021
Pacira Files Lawsuit Against eVenus for Patent Infringement
November 7, 2021
Pacira BioSciences Reports Third Quarter 2021 Financial Results
November 2, 2021
Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition
November 1, 2021
Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021
October 26, 2021
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
October 10, 2021
Pacira BioSciences to Host Investor Day on October 15th, 2021 in Tampa, FL
October 7, 2021
Pacira BioSciences Notified of Abbreviated New Drug Application Filing for EXPAREL®
October 3, 2021
Pacira Announces Commercial Production Underway with Enhanced EXPAREL Manufacturing Process at Swindon Facility
September 29, 2021
Pacira Announces Publication of Phase 3 Study of EXPAREL Infiltration in Pediatric Patients Undergoing Spinal or Cardiac Surgeries
September 20, 2021
Pacira BioSciences Reports Preliminary Net Product Sales of $42.3 Million for August 2021
September 14, 2021
Pacira BioSciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 7, 2021
Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021
August 9, 2021
Pacira BioSciences to Present at the 2021 Wedbush PacGrow Healthcare Virtual Conference
August 3, 2021
Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021
August 2, 2021
Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process
August 1, 2021
New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty
July 28, 2021
Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021
July 19, 2021
Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America
June 21, 2021
Pacira BioSciences Reports Preliminary Net Product Sales of $42.2 Million for May 2021
June 7, 2021
Pacira BioSciences Announces Top-line Results from Phase 3 STRIDE Study Evaluating EXPAREL as a Lower Extremity Nerve Block
May 25, 2021
Pacira BioSciences to Present at the 2021 Jefferies Virtual Healthcare Conference
May 24, 2021
Pacira BioSciences Announces Notice of Allowance of New Patent for EXPAREL
May 17, 2021
Pacira BioSciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference
May 11, 2021
Pacira BioSciences Reports Preliminary Net Product Sales of $44.6 Million for April 2021
May 10, 2021
Pacira BioSciences Reports First Quarter 2021 Financial Results and Business Update
May 3, 2021
Pacira to Report First Quarter 2021 Financial Results on Tuesday May 4, 2021
April 20, 2021
Pacira BioSciences Announces Investment in Spine BioPharma
April 19, 2021
Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology
April 13, 2021
Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021
April 6, 2021
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients
March 21, 2021
Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021
March 8, 2021
Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference
March 2, 2021
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results
February 24, 2021
Pacira to Report 2020 Financial Results on Thursday February 25, 2021
February 17, 2021
Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021
February 9, 2021
Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics
January 25, 2021
Pacira Reports Record Revenue for 2020 of $429.6 Million
January 6, 2021
Calls in 2021
- Pacira BioSciences (NASDAQ:PCRX) Q3 2021 Earnings Call
Nov 3, 2021
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q2 2021 Earnings Call
Aug 3, 2021
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q1 2021 Earnings Call
May 4, 2021
Transcript - Pacira BioSciences (NASDAQ:PCRX) Q4 2020 Earnings Call
Feb 25, 2021
Transcript
Decks in 2021
- Merger or Acquisition (October 2021)
Merger or acquisition · 12 slides · Oct 12, 2021